BAY94-9027 PK Study Comparing to Another Long Acting Product

NCT03364998 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Damoctocog (Jivi, BAY94-9027)
DRUG: Elocta

Sponsor

Bayer